Lisa Gill
Stock Analyst at JP Morgan
(3.15)
# 1,143
Out of 5,132 analysts
137
Total ratings
48.39%
Success rate
1.24%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAH Cardinal Health | Maintains: Neutral | $209 → $243 | $220.79 | +10.06% | 7 | Feb 10, 2026 | |
| COR Cencora | Maintains: Overweight | $417 → $419 | $360.83 | +16.12% | 4 | Feb 10, 2026 | |
| MCK McKesson | Maintains: Overweight | $983 → $1,107 | $934.75 | +18.43% | 15 | Feb 10, 2026 | |
| LH Labcorp Holdings | Maintains: Overweight | $317 → $319 | $282.63 | +12.87% | 3 | Feb 6, 2026 | |
| ELV Elevance Health | Maintains: Overweight | $394 → $397 | $346.80 | +14.48% | 7 | Feb 2, 2026 | |
| UNH UnitedHealth Group | Maintains: Overweight | $425 → $389 | $293.19 | +32.68% | 11 | Feb 2, 2026 | |
| MDLN Medline | Initiates: Overweight | $50 | $44.55 | +12.23% | 1 | Jan 12, 2026 | |
| CVS CVS Health | Maintains: Overweight | $93 → $101 | $78.48 | +28.70% | 6 | Dec 17, 2025 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $20 → $23 | $20.19 | +13.92% | 6 | Dec 17, 2025 | |
| PRVA Privia Health Group | Maintains: Overweight | $32 → $33 | $22.39 | +47.39% | 6 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $5 | $2.18 | +129.36% | 2 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $25 → $26 | $20.69 | +25.66% | 1 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $428 → $375 | $291.44 | +28.67% | 14 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $6 → $10 | $7.93 | +26.10% | 3 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $190 | $206.87 | -8.15% | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $29 → $30 | $23.54 | +27.44% | 2 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $40 → $41 | $35.42 | +15.75% | 4 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $257 → $256 | $184.10 | +39.05% | 6 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $18 | $37.81 | -52.39% | 2 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $5 | $8.36 | -40.19% | 4 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $28 | $15.46 | +81.11% | 4 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $9 | $4.65 | +93.55% | 9 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $9.60 | +87.50% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $135.35 | +191.84% | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $234.81 | -20.79% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $231.10 | -39.42% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $540.29 | -38.55% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $9 | $0.36 | +2,393.07% | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8 | $7.03 | +13.80% | 4 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $78.19 | +6.15% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $40.58 | +141.50% | 1 | Jan 6, 2023 |
Cardinal Health
Feb 10, 2026
Maintains: Neutral
Price Target: $209 → $243
Current: $220.79
Upside: +10.06%
Cencora
Feb 10, 2026
Maintains: Overweight
Price Target: $417 → $419
Current: $360.83
Upside: +16.12%
McKesson
Feb 10, 2026
Maintains: Overweight
Price Target: $983 → $1,107
Current: $934.75
Upside: +18.43%
Labcorp Holdings
Feb 6, 2026
Maintains: Overweight
Price Target: $317 → $319
Current: $282.63
Upside: +12.87%
Elevance Health
Feb 2, 2026
Maintains: Overweight
Price Target: $394 → $397
Current: $346.80
Upside: +14.48%
UnitedHealth Group
Feb 2, 2026
Maintains: Overweight
Price Target: $425 → $389
Current: $293.19
Upside: +32.68%
Medline
Jan 12, 2026
Initiates: Overweight
Price Target: $50
Current: $44.55
Upside: +12.23%
CVS Health
Dec 17, 2025
Maintains: Overweight
Price Target: $93 → $101
Current: $78.48
Upside: +28.70%
Alignment Healthcare
Dec 17, 2025
Maintains: Overweight
Price Target: $20 → $23
Current: $20.19
Upside: +13.92%
Privia Health Group
Nov 13, 2025
Maintains: Overweight
Price Target: $32 → $33
Current: $22.39
Upside: +47.39%
Nov 11, 2025
Maintains: Overweight
Price Target: $6 → $5
Current: $2.18
Upside: +129.36%
Nov 11, 2025
Maintains: Neutral
Price Target: $25 → $26
Current: $20.69
Upside: +25.66%
Nov 4, 2025
Maintains: Overweight
Price Target: $428 → $375
Current: $291.44
Upside: +28.67%
Sep 18, 2025
Upgrades: Neutral
Price Target: $6 → $10
Current: $7.93
Upside: +26.10%
May 6, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $206.87
Upside: -8.15%
Mar 19, 2025
Maintains: Overweight
Price Target: $29 → $30
Current: $23.54
Upside: +27.44%
Mar 6, 2025
Maintains: Overweight
Price Target: $40 → $41
Current: $35.42
Upside: +15.75%
Feb 18, 2025
Maintains: Neutral
Price Target: $257 → $256
Current: $184.10
Upside: +39.05%
Dec 17, 2024
Downgrades: Neutral
Price Target: $18
Current: $37.81
Upside: -52.39%
Dec 17, 2024
Downgrades: Underweight
Price Target: $5
Current: $8.36
Upside: -40.19%
Dec 3, 2024
Maintains: Neutral
Price Target: $38 → $28
Current: $15.46
Upside: +81.11%
Aug 26, 2024
Maintains: Neutral
Price Target: $16 → $9
Current: $4.65
Upside: +93.55%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $9.60
Upside: +87.50%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $135.35
Upside: +191.84%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $234.81
Upside: -20.79%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $231.10
Upside: -39.42%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $540.29
Upside: -38.55%
Jan 5, 2024
Downgrades: Neutral
Price Target: $17 → $9
Current: $0.36
Upside: +2,393.07%
Nov 17, 2023
Maintains: Neutral
Price Target: $10 → $8
Current: $7.03
Upside: +13.80%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $78.19
Upside: +6.15%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $40.58
Upside: +141.50%